The GPHF-Minilab® - Focusing on Prevalent Medicines against Infectious Diseases

The GPHF-Minilab focuses its work on a range of 57 drug compounds instantly life-threatened when diluted down to nothing. They have been selected on the basis of prevailing prescription practices, public health interest and existing counterfeit case reports, the current short list consisting of common antimicrobials, anthelminthics, anti(retro)virals, antimalarials, antituberculosis and some other medicines including their appropriate fixed-dose combination products. The list is regularly extended.

Antimicrobials
Amoxicillin Ampicillin Azithromycin 
Cefalexin  Cefixime Cefuroxime 
Chloramphenicol Ciprofloxacin Cloxacillin  
Erythromycin Levofloxacin Metronidazole 
Moxifloxacin Phenoxymethylpenicillin  Sulfamethoxazole 
Tetracycline Trimethoprim 
 
Antimalarials
Amodiaquine Artemether Artesunate  
Atovaquone Chloroquine Dihydroartemisinin 
Halofantrine Lumefantrine Mefloquine  
Piperaquine Primaquine Proguanil 
Pyrimethamine Quinine  Sulfadoxine 
 
Anti(retro)virals
Didanosine Indinavir Lamivudine  
Nevirapine Oseltamivir Stavudine  
Zidovudine 
 
Anti-TB medicines
Ciprofloxacin Cycloserine Ethambutol 
Ethionamide Isoniazid Levofloxacin 
Moxifloxacin Prothionamide Pyrazinamide  
Rifampicin 
 
Anthelminthics
Albendazole Mebendazole Praziquantel 
 
Antifungals
Griseofulvin 
 
Non Anti-Infectives
Acetylsalicylic acid Aminophylline Furosemide  
Glibenclamide Paracetamol Prednisolone  
Salbutamol